Ocata Therapeutics CEO and leadership

Q: Who is the CEO of Ocata Therapeutics?

The CEO of Ocata Therapeutics is Michael West.

Zippia score 3.6

Ocata Therapeutics CEO and executives

Executive Summary. Based on our data team's research, Michael West is the Ocata Therapeutics's CEO. Ocata Therapeutics has 37 employees, of which 10 are in a leadership position.

Here are further demographic highlights of the leadership team:

The Ocata Therapeutics executive team is 10% female and 90% male.
66% of the management team is White.
19% of Ocata Therapeutics management is Hispanic or Latino.
10% of the management team is Black or African American.

Work at Ocata Therapeutics?

Share your experience

Rate Ocata Therapeutics' leaders' effectiveness in guiding the company.

Name & TitleBio

Michael West

CEO

Michael D. West, Ph.D., is the founder and CEO of AgeX Therapeutics, Inc. He received his Ph.D. from Baylor College of Medicine in 1989 concentrating on the biology of cellular ageing. He has focused his academic and business career on the application of developmental biology to age-related degenerative disease. He was the founder and first CEO of Geron Corporation (Nasdaq: GERN), and from 1992 to 1998, he held various positions, including CEO, Director, and Vice President. From 1998 to 2007, Dr West held positions as CEO, President, and Chief Scientific Officer at Advanced Cell Technology, Inc. (ACT), which was eventually acquired by Astellas Pharma, Inc. From 2007 to 2018, he was CEO/Co-CEO of BioTime, Inc. (NYSE American: BTX).

Gregory Perry

Board Member

Alan Shapiro

Board Member

Constance Cepko

Board Member

Gary Rabin

Board Member

Joseph Vacanti

Board Member

Michael Heffernan

Board Member

Michael Longaker

Board Member

Robert Langer

Board Member

Robert Lanza

Various Roles

Dr. Robert Lanza is the Head of Astellas Global Regenerative Medicine and Chief Scientific Officer of the Astellas Institute for Regenerative Medicine. Robert Lanza, MD is also an Adjunct Professor at Wake Forest School of Medicine.

Do you work at Ocata Therapeutics?

Does leadership effectively guide Ocata Therapeutics toward its goals?

Ocata Therapeutics jobs

Ocata Therapeutics board members

Name & TitleBio

Gregory Perry

Board Member

Alan Shapiro

Board Member

Constance Cepko

Board Member

Gary Rabin

Board Member

Joseph Vacanti

Board Member

Michael Heffernan

Board Member

Michael Longaker

Board Member

Robert Langer

Board Member

Ocata Therapeutics executives FAQs

Who is the CEO of Ocata Therapeutics?

Related company executives

Working at related companies

Related company jobs

Most in demand jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of Ocata Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ocata Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Ocata Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Ocata Therapeutics. The data presented on this page does not represent the view of Ocata Therapeutics and its employees or that of Zippia.

Ocata Therapeutics may also be known as or be related to OCATA THERAPEUTICS, INC. and Ocata Therapeutics.